Joseph Talamo

Officer, Caladrius Biosciences.

Companies

INTENSITY THERAPEUTICS, INC.Chief financial officer Dec 12, 2023 to now¹
Caladrius BiosciencesChief financial officer Aug 12, 2016 to Jan 15, 2020²
Caladrius BiosciencesOfficer Jul 1, 2011 to Jan 27, 2017³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

INTENSITY THERAPEUTICS, INC. INTS2,239 shares⁴$7.1K at $3.19Jun 30, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 30, 2026Granted 1,093 shares at $3.49 of INTENSITY THERAPEUTICS, INC.⁴
Dec 31, 2025Granted 14,482 shares at $0.26 of INTENSITY THERAPEUTICS, INC.⁵
Jun 30, 2025Granted 14,179 shares at $0.26 of INTENSITY THERAPEUTICS, INC.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARINTENSITY THERAPEUTICS, INC., Chief financial officer
2
SEC EDGARCaladrius Biosciences, Chief financial officer
3
SEC EDGARCaladrius Biosciences, Officer
4
SEC EDGARINTENSITY THERAPEUTICS, INC. shares after the filing of Jun 30, 2026
5
SEC EDGARForm 4 filed Jan 5, 2026
6
SEC EDGARForm 4 filed Jul 2, 2025